Interventional Strategies in Cancer-induced Cardiovascular Disease
Purpose of Review To highlight the range of illnesses and procedures that the interventional onco-cardiologists face in their daily practice, along with the recent additions to anti-cancer therapies and their related cardiotoxicity. Recent findings Immune checkpoint inhibitors (ICI) are not devoid o...
Gespeichert in:
| Veröffentlicht in: | Current oncology reports 2021-11, Vol.23 (11), p.133, Article 133 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 11 |
| container_start_page | 133 |
| container_title | Current oncology reports |
| container_volume | 23 |
| creator | Pushparaji, Bala Donisan, Teodora Balanescu, Dinu V. Palaskas, Nicolas Kim, Peter Lopez-Mattei, Juan Cilingiroglu, Mehmet Hassan, Saamir A. Boudoulas, Konstantinos Dean Marmagkiolis, Konstantinos Hajjar, Ludhmila Abrahao Iliescu, Cezar A. |
| description | Purpose of Review
To highlight the range of illnesses and procedures that the interventional onco-cardiologists face in their daily practice, along with the recent additions to anti-cancer therapies and their related cardiotoxicity.
Recent findings
Immune checkpoint inhibitors (ICI) are not devoid of cardiotoxicity as thought earlier and lead to an increased incidence of myocarditis. Transcatheter valve replacement has been shown to be a safer alternative to surgical replacement in cancer patients.
Summary
Interventional onco-cardiology is a novel field that addresses cardiovascular diseases in the setting of cancer. Traditionally excluding cancer patients from clinical trials has led to a dearth of information needed to tackle cardiac conditions like Takotsubo cardiomyopathy, malignant pericardial effusions, and radiation-induced vascular diseases encountered either exclusively or predominantly in this high-risk population. This review discusses the various treatment options available in the interventional armamentarium with a particular focus on ICI—myocarditis and transcatheter aortic valve replacement in cancer patients. |
| doi_str_mv | 10.1007/s11912-021-01113-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2576742883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2576742883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-9edbd65a39cfbf4852c225a96252836ce754a5bf12ddba02bead4aaca22a748a3</originalsourceid><addsrcrecordid>eNp9kE1PwzAMhiMEYmPwBzigSpwDidP04wjja9IkDsA5chN36rS1I2kn7d_T0QE3Trbl931tPYxdSnEjhUhvg5S5BC5AciGlVHx3xMZSq5gnkOTH-x4UV2kuRuwshKUQIEQmTtlIxToVkMsxu5_VLfkt1W3V1LiK3lqPLS0qClFVR1OsLXle1a6z5PrRu6rZYrDdCn30UAXCQOfspMRVoItDnbCPp8f36Qufvz7PpndzblWqW56TK1yiUeW2LMo402ABNOYJaMhUYinVMeqilOBcgQIKQhcjWgTANM5QTdj1kLvxzWdHoTXLpvP908GATpM0hixTvQoGlfVNCJ5Ks_HVGv3OSGH22MyAzfTYzDc2s-tNV4forliT-7X8cOoFahCEflUvyP_d_if2C928eTM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2576742883</pqid></control><display><type>article</type><title>Interventional Strategies in Cancer-induced Cardiovascular Disease</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Pushparaji, Bala ; Donisan, Teodora ; Balanescu, Dinu V. ; Palaskas, Nicolas ; Kim, Peter ; Lopez-Mattei, Juan ; Cilingiroglu, Mehmet ; Hassan, Saamir A. ; Boudoulas, Konstantinos Dean ; Marmagkiolis, Konstantinos ; Hajjar, Ludhmila Abrahao ; Iliescu, Cezar A.</creator><creatorcontrib>Pushparaji, Bala ; Donisan, Teodora ; Balanescu, Dinu V. ; Palaskas, Nicolas ; Kim, Peter ; Lopez-Mattei, Juan ; Cilingiroglu, Mehmet ; Hassan, Saamir A. ; Boudoulas, Konstantinos Dean ; Marmagkiolis, Konstantinos ; Hajjar, Ludhmila Abrahao ; Iliescu, Cezar A.</creatorcontrib><description>Purpose of Review
To highlight the range of illnesses and procedures that the interventional onco-cardiologists face in their daily practice, along with the recent additions to anti-cancer therapies and their related cardiotoxicity.
Recent findings
Immune checkpoint inhibitors (ICI) are not devoid of cardiotoxicity as thought earlier and lead to an increased incidence of myocarditis. Transcatheter valve replacement has been shown to be a safer alternative to surgical replacement in cancer patients.
Summary
Interventional onco-cardiology is a novel field that addresses cardiovascular diseases in the setting of cancer. Traditionally excluding cancer patients from clinical trials has led to a dearth of information needed to tackle cardiac conditions like Takotsubo cardiomyopathy, malignant pericardial effusions, and radiation-induced vascular diseases encountered either exclusively or predominantly in this high-risk population. This review discusses the various treatment options available in the interventional armamentarium with a particular focus on ICI—myocarditis and transcatheter aortic valve replacement in cancer patients.</description><identifier>ISSN: 1523-3790</identifier><identifier>EISSN: 1534-6269</identifier><identifier>DOI: 10.1007/s11912-021-01113-y</identifier><identifier>PMID: 34570291</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aortic valve ; Cancer ; Cardio-oncology (EH Yang ; Cardiomyopathy ; Cardiotoxicity ; Cardiotoxicity - etiology ; Cardiovascular diseases ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - therapy ; Clinical trials ; Heart diseases ; Humans ; Immune checkpoint inhibitors ; Immune Checkpoint Inhibitors - adverse effects ; Medicine ; Medicine & Public Health ; Myocarditis ; Myocarditis - chemically induced ; Neoplasms - complications ; Oncology ; Patients ; Section Editor ; Takotsubo Cardiomyopathy - etiology ; Takotsubo Cardiomyopathy - therapy ; Topical Collection on Cardio-oncology ; Transcatheter Aortic Valve Replacement ; Vascular diseases</subject><ispartof>Current oncology reports, 2021-11, Vol.23 (11), p.133, Article 133</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>The Author(s) 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-9edbd65a39cfbf4852c225a96252836ce754a5bf12ddba02bead4aaca22a748a3</citedby><cites>FETCH-LOGICAL-c375t-9edbd65a39cfbf4852c225a96252836ce754a5bf12ddba02bead4aaca22a748a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11912-021-01113-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11912-021-01113-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34570291$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pushparaji, Bala</creatorcontrib><creatorcontrib>Donisan, Teodora</creatorcontrib><creatorcontrib>Balanescu, Dinu V.</creatorcontrib><creatorcontrib>Palaskas, Nicolas</creatorcontrib><creatorcontrib>Kim, Peter</creatorcontrib><creatorcontrib>Lopez-Mattei, Juan</creatorcontrib><creatorcontrib>Cilingiroglu, Mehmet</creatorcontrib><creatorcontrib>Hassan, Saamir A.</creatorcontrib><creatorcontrib>Boudoulas, Konstantinos Dean</creatorcontrib><creatorcontrib>Marmagkiolis, Konstantinos</creatorcontrib><creatorcontrib>Hajjar, Ludhmila Abrahao</creatorcontrib><creatorcontrib>Iliescu, Cezar A.</creatorcontrib><title>Interventional Strategies in Cancer-induced Cardiovascular Disease</title><title>Current oncology reports</title><addtitle>Curr Oncol Rep</addtitle><addtitle>Curr Oncol Rep</addtitle><description>Purpose of Review
To highlight the range of illnesses and procedures that the interventional onco-cardiologists face in their daily practice, along with the recent additions to anti-cancer therapies and their related cardiotoxicity.
Recent findings
Immune checkpoint inhibitors (ICI) are not devoid of cardiotoxicity as thought earlier and lead to an increased incidence of myocarditis. Transcatheter valve replacement has been shown to be a safer alternative to surgical replacement in cancer patients.
Summary
Interventional onco-cardiology is a novel field that addresses cardiovascular diseases in the setting of cancer. Traditionally excluding cancer patients from clinical trials has led to a dearth of information needed to tackle cardiac conditions like Takotsubo cardiomyopathy, malignant pericardial effusions, and radiation-induced vascular diseases encountered either exclusively or predominantly in this high-risk population. This review discusses the various treatment options available in the interventional armamentarium with a particular focus on ICI—myocarditis and transcatheter aortic valve replacement in cancer patients.</description><subject>Aortic valve</subject><subject>Cancer</subject><subject>Cardio-oncology (EH Yang</subject><subject>Cardiomyopathy</subject><subject>Cardiotoxicity</subject><subject>Cardiotoxicity - etiology</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cardiovascular Diseases - therapy</subject><subject>Clinical trials</subject><subject>Heart diseases</subject><subject>Humans</subject><subject>Immune checkpoint inhibitors</subject><subject>Immune Checkpoint Inhibitors - adverse effects</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Myocarditis</subject><subject>Myocarditis - chemically induced</subject><subject>Neoplasms - complications</subject><subject>Oncology</subject><subject>Patients</subject><subject>Section Editor</subject><subject>Takotsubo Cardiomyopathy - etiology</subject><subject>Takotsubo Cardiomyopathy - therapy</subject><subject>Topical Collection on Cardio-oncology</subject><subject>Transcatheter Aortic Valve Replacement</subject><subject>Vascular diseases</subject><issn>1523-3790</issn><issn>1534-6269</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kE1PwzAMhiMEYmPwBzigSpwDidP04wjja9IkDsA5chN36rS1I2kn7d_T0QE3Trbl931tPYxdSnEjhUhvg5S5BC5AciGlVHx3xMZSq5gnkOTH-x4UV2kuRuwshKUQIEQmTtlIxToVkMsxu5_VLfkt1W3V1LiK3lqPLS0qClFVR1OsLXle1a6z5PrRu6rZYrDdCn30UAXCQOfspMRVoItDnbCPp8f36Qufvz7PpndzblWqW56TK1yiUeW2LMo402ABNOYJaMhUYinVMeqilOBcgQIKQhcjWgTANM5QTdj1kLvxzWdHoTXLpvP908GATpM0hixTvQoGlfVNCJ5Ks_HVGv3OSGH22MyAzfTYzDc2s-tNV4forliT-7X8cOoFahCEflUvyP_d_if2C928eTM</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Pushparaji, Bala</creator><creator>Donisan, Teodora</creator><creator>Balanescu, Dinu V.</creator><creator>Palaskas, Nicolas</creator><creator>Kim, Peter</creator><creator>Lopez-Mattei, Juan</creator><creator>Cilingiroglu, Mehmet</creator><creator>Hassan, Saamir A.</creator><creator>Boudoulas, Konstantinos Dean</creator><creator>Marmagkiolis, Konstantinos</creator><creator>Hajjar, Ludhmila Abrahao</creator><creator>Iliescu, Cezar A.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20211101</creationdate><title>Interventional Strategies in Cancer-induced Cardiovascular Disease</title><author>Pushparaji, Bala ; Donisan, Teodora ; Balanescu, Dinu V. ; Palaskas, Nicolas ; Kim, Peter ; Lopez-Mattei, Juan ; Cilingiroglu, Mehmet ; Hassan, Saamir A. ; Boudoulas, Konstantinos Dean ; Marmagkiolis, Konstantinos ; Hajjar, Ludhmila Abrahao ; Iliescu, Cezar A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-9edbd65a39cfbf4852c225a96252836ce754a5bf12ddba02bead4aaca22a748a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aortic valve</topic><topic>Cancer</topic><topic>Cardio-oncology (EH Yang</topic><topic>Cardiomyopathy</topic><topic>Cardiotoxicity</topic><topic>Cardiotoxicity - etiology</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cardiovascular Diseases - therapy</topic><topic>Clinical trials</topic><topic>Heart diseases</topic><topic>Humans</topic><topic>Immune checkpoint inhibitors</topic><topic>Immune Checkpoint Inhibitors - adverse effects</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Myocarditis</topic><topic>Myocarditis - chemically induced</topic><topic>Neoplasms - complications</topic><topic>Oncology</topic><topic>Patients</topic><topic>Section Editor</topic><topic>Takotsubo Cardiomyopathy - etiology</topic><topic>Takotsubo Cardiomyopathy - therapy</topic><topic>Topical Collection on Cardio-oncology</topic><topic>Transcatheter Aortic Valve Replacement</topic><topic>Vascular diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pushparaji, Bala</creatorcontrib><creatorcontrib>Donisan, Teodora</creatorcontrib><creatorcontrib>Balanescu, Dinu V.</creatorcontrib><creatorcontrib>Palaskas, Nicolas</creatorcontrib><creatorcontrib>Kim, Peter</creatorcontrib><creatorcontrib>Lopez-Mattei, Juan</creatorcontrib><creatorcontrib>Cilingiroglu, Mehmet</creatorcontrib><creatorcontrib>Hassan, Saamir A.</creatorcontrib><creatorcontrib>Boudoulas, Konstantinos Dean</creatorcontrib><creatorcontrib>Marmagkiolis, Konstantinos</creatorcontrib><creatorcontrib>Hajjar, Ludhmila Abrahao</creatorcontrib><creatorcontrib>Iliescu, Cezar A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Current oncology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pushparaji, Bala</au><au>Donisan, Teodora</au><au>Balanescu, Dinu V.</au><au>Palaskas, Nicolas</au><au>Kim, Peter</au><au>Lopez-Mattei, Juan</au><au>Cilingiroglu, Mehmet</au><au>Hassan, Saamir A.</au><au>Boudoulas, Konstantinos Dean</au><au>Marmagkiolis, Konstantinos</au><au>Hajjar, Ludhmila Abrahao</au><au>Iliescu, Cezar A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interventional Strategies in Cancer-induced Cardiovascular Disease</atitle><jtitle>Current oncology reports</jtitle><stitle>Curr Oncol Rep</stitle><addtitle>Curr Oncol Rep</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>23</volume><issue>11</issue><spage>133</spage><pages>133-</pages><artnum>133</artnum><issn>1523-3790</issn><eissn>1534-6269</eissn><abstract>Purpose of Review
To highlight the range of illnesses and procedures that the interventional onco-cardiologists face in their daily practice, along with the recent additions to anti-cancer therapies and their related cardiotoxicity.
Recent findings
Immune checkpoint inhibitors (ICI) are not devoid of cardiotoxicity as thought earlier and lead to an increased incidence of myocarditis. Transcatheter valve replacement has been shown to be a safer alternative to surgical replacement in cancer patients.
Summary
Interventional onco-cardiology is a novel field that addresses cardiovascular diseases in the setting of cancer. Traditionally excluding cancer patients from clinical trials has led to a dearth of information needed to tackle cardiac conditions like Takotsubo cardiomyopathy, malignant pericardial effusions, and radiation-induced vascular diseases encountered either exclusively or predominantly in this high-risk population. This review discusses the various treatment options available in the interventional armamentarium with a particular focus on ICI—myocarditis and transcatheter aortic valve replacement in cancer patients.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>34570291</pmid><doi>10.1007/s11912-021-01113-y</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1523-3790 |
| ispartof | Current oncology reports, 2021-11, Vol.23 (11), p.133, Article 133 |
| issn | 1523-3790 1534-6269 |
| language | eng |
| recordid | cdi_proquest_journals_2576742883 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Aortic valve Cancer Cardio-oncology (EH Yang Cardiomyopathy Cardiotoxicity Cardiotoxicity - etiology Cardiovascular diseases Cardiovascular Diseases - etiology Cardiovascular Diseases - therapy Clinical trials Heart diseases Humans Immune checkpoint inhibitors Immune Checkpoint Inhibitors - adverse effects Medicine Medicine & Public Health Myocarditis Myocarditis - chemically induced Neoplasms - complications Oncology Patients Section Editor Takotsubo Cardiomyopathy - etiology Takotsubo Cardiomyopathy - therapy Topical Collection on Cardio-oncology Transcatheter Aortic Valve Replacement Vascular diseases |
| title | Interventional Strategies in Cancer-induced Cardiovascular Disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T21%3A58%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interventional%20Strategies%20in%20Cancer-induced%20Cardiovascular%20Disease&rft.jtitle=Current%20oncology%20reports&rft.au=Pushparaji,%20Bala&rft.date=2021-11-01&rft.volume=23&rft.issue=11&rft.spage=133&rft.pages=133-&rft.artnum=133&rft.issn=1523-3790&rft.eissn=1534-6269&rft_id=info:doi/10.1007/s11912-021-01113-y&rft_dat=%3Cproquest_cross%3E2576742883%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2576742883&rft_id=info:pmid/34570291&rfr_iscdi=true |